Vanderbilt Institute for Clinical and Translational Research (VICTR)

范德比尔特临床与转化研究所 (VICTR)

• 批准号: 10591572
• 负责人: Gordon R Bernard
• 金额: $ 1095.41万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-06-01 至 2027-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10591572
• 关键词: Academic Medical Centers; Acceleration; Black race; COVID-19 mortality; Clinical Research; Clinical Sciences; Collaborations; Communities; Disease; Economics; Ensure; Equity; Foundations; Funding; Health; Health Sciences; Healthcare; Healthcare Systems; Home; Homelessness; Imprisonment; Incidence; Inequity; Informatics; Infrastructure; Institution; International; Knowledge; Learning; Methodology; Methods; Mission; Morbidity - disease rate; Multi-Institutional Clinical Trial; Pharmaceutical Preparations; Population; Process; Race; Research; Research Infrastructure; Research Methodology; Research Personnel; Resources; Role; Science; System; Textiles; Time; Translational Research; Translations; Vision; community engagement; design; drug repurposing; ethnic minority population; health disparity; health equity; improved; informatics tool; innovation; medical schools; multidimensional data; novel; operation; pandemic disease; pragmatic trial; programs; racial minority population; skills; social; success; trial design; voucher

Contact PD/PI: Bernard, Gordon R The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional and integrated clinical and translational (C&T) research infrastructure that has raised the quality and scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry, the nation's oldest historically black academic health science institution. VICTR will contribute to the mission of the CTSA program while leveraging unique resources and expertise within VICTR's Hub and elevating the role of health equity in C&T research with these new aims: 1) Leverage VICTR's strong collaborative energy to enhance team science methodologies, integrate community engagement principles for all stages of research, and implement programs designed to support health equity in research; 2) Develop and share multi-dimensional data organization methods and informatics tools to promulgate innovation, efficiency, quality, and equity in research; 3) Ensure the translational science workforce is diverse and has the skills, knowledge, and resources necessary to advance translation of discoveries within a health equity framework; 4) Support the efficiency, quality, representativeness, and impact of local studies and `raise the bar' for acceptable scientific standards in research conduct; 5) Support the efficiency, quality, representativeness, and impact of multi-site clinical trials by building and disseminating streamlining programs and promoting novel trial designs; and 6) Utilize unique institutional capabilities to enable the conduct of pragmatic trials during healthcare operations and repurpose existing drugs for new indications.

联系人 PD/PI：Bernard, Gordon R 范德比尔特临床与转化研究所 (VICTR) 是一个功能强大、 综合临床和转化 (C&T) 研究基础设施提高了质量和 范德比尔特大学和长期合作伙伴 Meharry 进行的研究具有科学严谨性 全国历史最悠久的黑人学术健康科学机构。 VICTR 将致力于 CTSA 计划的使命，同时利用 VICTR 内独特的资源和专业知识 中心化并提升健康公平在 C&T 研究中的作用，实现以下新目标：1) 杠杆作用 VICTR 强大的协作能力可增强团队科学方法、整合 研究各个阶段的社区参与原则，并实施设计的计划 支持研究中的健康公平； 2）开发和共享多维数据组织 传播研究创新、效率、质量和公平的方法和信息学工具； 3) 确保转化科学人员队伍多元化并拥有技能、知识和能力 在健康公平框架内推进发现转化所需的资源； 4） 支持地方研究的效率、质量、代表性和影响力并“提高标准” 研究行为中可接受的科学标准； 5）支持效率、质量、 通过建立和传播多中心临床试验的代表性和影响 简化计划并推广新颖的试验设计； 6) 利用独特的制度 能够在医疗保健运营和重新利用期间进行实用试验的能力 现有药物的新适应症。